Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice

Infection and Immunity

Volumn 74, Issue 10, 2006, Pages 5506-5512

  Zarantonelli, Maria Leticia ^a   Huerre, Michel ^a   Taha, Muhamed Kheir ^a   Alonso, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID A; LIPOOLIGOSACCHARIDE; MURINE INTERLEUKIN 8 HOMOLOG; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; GENE EXPRESSION; HOST PATHOGEN INTERACTION; INFLAMMATION; LOBAR PNEUMONIA; LPXA GENE; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVERTANT; RFAD GENE;

ANIMALS; CHEMOKINES; CYTOKINES; FEMALE; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; MENINGOCOCCAL INFECTIONS; MICE; MICE, INBRED BALB C; MUTATION; NEISSERIA MENINGITIDIS; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 33749253907     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00655-06     Document Type: Article

References (28)

1. Alonso, J. M., A. Guiyoule, M. L. Zarantonelli, F. Ramisse, R. Pires, A. Antignac, A. E. Deghmane, M. Huerre, S. van der Werf, and M. K. Taha. 2003. A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol. Lett. 222:99-106.
2. Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7:401-420.
3. Brandtzaeg, P., and M. van Deuren. 2002. Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr. Opin. Infect. Dis. 15:247-252.
4. Deghmane, A. E., S. Petit, A. Topilko, Y. Pereira, D. Giorgini, M. Larribe, and M. K. Taha. 2000. Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator. EMBO J. 19:1068-1078.
5. Galloway, S. M., and C. R. Raetz. 1990. A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis. J. Biol. Chem. 265:6394-6402.
6. Girardin, S. E., I. G. Boneca, L. A. Carneiro, A. Antignac, M. Jehanno, J. Viala, K. Tedin, M. K. Taha, A. Labigne, U. Zahringer, A. J. Coyle, P. S. DiStefano, J. Bertin, P. J. Sansonetti, and D. J. Philpott. 2003. Nodi detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587.
7. Hammerschmidt, S., R. Hilse, J. P. van Putten, R. Gerardy-Schahn, A. Unkmeir, and M. Frosch. 1996. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J. 15:192-198.
8. Ingalls, R. R., E. Lien, and D. T. Golenbock. 2001. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2. Infect. Immun. 69:2230-2236.
9. Kahler, C. M., and D. S. Stephens. 1998. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit. Rev. Microbiol. 24:281-334.
10. Kellogg, D. S., Jr., W. L. Peacock, Jr., W. E. Deacon, L. Brown, and D. I. Pirkle. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85:1274-1279.
11. Moller, A. S., A. Bjerre, B. Brusletto, G. B. Joo, P. Brandtzaeg, and P. Kierulf. 2005. Chemokine patterns in meningococcal disease. J. Infect. Dis. 191:768-775.
12. Plant, L., J. Sundqvist, S. Zughaier, L. Lovkvist, D. S. Stephens, and A. B. Jonsson. 2006. Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis. Infect. Immun. 74:1360-1367.
13. Pridmore, A. C., D. H. Wyllie, F. Abdillahi, L. Steeghs, P. van der Ley, S. K. Dower, and R. C. Read. 2001. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J. Infect. Dis. 183:89-96.
14. Quagliarello, V., and W. M. Scheld. 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327:864-872.
15. Ramphal, R., V. Balloy, M. Huerre, M. Si-Tahar, and M. Chignard. 2005. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J. Immunol. 175:3927-3934.
16. Sprong, T., N. Stikkelbroeck, P. van der Ley, L. Steeghs, L. van Alphen, N. Klein, M. G. Netea, J. W. van der Meer, and M. van Deuren. 2001. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J. Leukoc. Biol. 70:283-288.
17. Sprang, T., P. van der Ley, L. Steeghs, W. J. Taw, T. J. Verver-Janssen, M. G. Netea, J. W. van der Meer, and M. van Deuren. 2002. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4. Eur. Cytokine Netw. 13:411-417.
18. Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392:449-450.
19. Steeghs, L., M. P. Jennings, J. T. Poolman, and P. van der Ley. 1997. Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis. Gene 190:263-270.
20. Touqui, L., M. Paya, F. Thouron, A. Guiyoule, M. L. Zarantonelli, D. Leduc, Y. Wu, M. K. Taha, and J. M. Alonso. 2005. Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages. FEBS Lett. 579:4923-4927.
21. Unkmeir, A., U. Kammerer, A. Stade, C. Hubner, S. Haller, A. Kolb-Maurer, M. Frosch, and G. Dietrich. 2002. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect. Immun. 70:2454-2462.
22. Uronen, H., A. J. Williams, G. Dixon, S. R. Andersen, P. Van Der Ley, M. Van Deuren, R. E. Callard, and N. Klein. 2000. Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS). Clin. Exp. Immunol. 122:312-315.
23. van der Ley, P., and L. Steeghs. 2003. Lessons from an LPS-deficient Neisseria meningitidis mutant. J. Endotoxin Res. 9:124-128.
24. van der Ley, P., L. Steeghs, H. J. Hamstra, J. ten Hove, B. Zomer, and L. van Alphen. 2001. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69:5981-5990.
25. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166.
26. Vogel, U., and M. Frosch. 1999. Mechanisms of neisserial serum resistance. Mol. Microbiol. 32:1133-1139.
27. Zarantonelli, M. L., J. P. Carlier, J. M. Alonso, and M. K. Taha. 2003. Insertional inactivation of the lpxA gene involved in the biosynthesis of lipid A in Neisseria meningitidis resulted in lpxA/lpxA::aph-3′ heterodiploids. FEMS Microbiol. Lett. 226:51-56.
28. Zughaier, S. M., Y. L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens. 2004. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72:371-380.